Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other auto...
Q32 Bio Inc. (NASDAQ:QTTB) Sees Large Increase in Short Interest
Q32 Bio Enters Underwriting for $18.25 Offering, Net Proceeds ~$188M; Option Lifts to ~$216M
Why Is Q32 Bio Stock Falling Wednesday?
$100 Invested In Q32 Bio 5 Years Ago Would Be Worth This Much Today
Q32 Bio Announces Pricing of $200 Million Public Offering of Common Stock and Pre-Funded Warrants | QTTB Stock News
Ericsson, Q32 Bio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session